CAR-T treatment for cancer: prospects and challenges

被引：4
|
作者：
Chen, Ran [1 ]
Chen, Lei [2 ]
Wang, Chaoqun [1 ]
Zhu, Hua [1 ]
Gu, Lijuan [3 ]
Li, Yuntao [1 ]
Xiong, Xiaoxing [1 ]
Chen, Gang [1 ]
Jian, Zhihong [1 ]
机构：
[1] Wuhan Univ, Renmin Hosp, Dept Neurosurg, Wuhan, Peoples R China
[2] Wuhan Univ, Renmin Hosp, Canc Ctr, Wuhan, Peoples R China
[3] Wuhan Univ, Renmin Hosp, Cent Lab, Wuhan, Peoples R China
来源：
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
关键词：
CAR-T; cancer immunotherapy; tumor microenvironment; immunosuppressive environment; immune checkpoint; CELL THERAPY; B-CELL; ADOPTIVE IMMUNOTHERAPY; TUMOR MICROENVIRONMENT; ACTIVATION; CYTOKINE; METABOLISM; LYMPHOMA; DRIVER; STROMA;
D O I：
10.3389/fonc.2023.1288383
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Chimeric antigen receptor (CAR-T) cell therapy has been widely used in hematological malignancies and has achieved remarkable results, but its long-term efficacy in solid tumors is greatly limited by factors such as the tumor microenvironment (TME). In this paper, we discuss the latest research and future views on CAR-T cell cancer immunotherapy, compare the different characteristics of traditional immunotherapy and CAR-T cell therapy, introduce the latest progress in CAR-T cell immunotherapy, and analyze the obstacles that hinder the efficacy of CAR-T cell therapy, including immunosuppressive factors, metabolic energy deficiency, and physical barriers. We then further discuss the latest therapeutic strategies to overcome these barriers, as well as management decisions regarding the possible safety issues of CAR-T cell therapy, to facilitate solutions to the limited use of CAR-T immunotherapy.
引用
收藏
页数：13
相关论文
共 50 条
  • [1] Prospects and challenges of CAR-T in the treatment of ovarian cancer
    Chen, Biqing
    Liu, Jiaqi
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 133
  • [2] Prospects and challenges of CAR-T cell therapy combined with ICIs
    Lv, Yufan
    Luo, Xinyu
    Xie, Zhuoyi
    Qiu, Jieya
    Yang, Jinsai
    Deng, Yuqi
    Long, Rou
    Tang, Guiyang
    Zhang, Chaohui
    Zuo, Jianhong
    [J]. FRONTIERS IN ONCOLOGY, 2024, 14
  • [3] CAR-T IMMUNOTHERAPY - RECENT ADVANCES AND CURRENT CHALLENGES IN CANCER TREATMENT: A REVIEW
    Ronowicz-pilarczyk, Joanna
    [J]. ACTA POLONIAE PHARMACEUTICA, 2024, 81 (02): : 227 - 237
  • [4] CAR-T therapy: Prospects in targeting cancer stem cells
    Cui, Xiaoyue
    Liu, Rui
    Duan, Lian
    Cao, Dan
    Zhang, Qiaoling
    Zhang, Aijie
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2021, 25 (21) : 9891 - 9904
  • [5] CAR-T Cells for the Treatment of Lung Cancer
    Chocarro, Luisa
    Arasanz, Hugo
    Fernandez-Rubio, Leticia
    Blanco, Ester
    Echaide, Miriam
    Bocanegra, Ana
    Teijeira, Lucia
    Garnica, Maider
    Morilla, Idoia
    Martinez-Aguillo, Maite
    Pineiro-Hermida, Sergio
    Ramos, Pablo
    Lasarte, Juan Jose
    Vera, Ruth
    Kochan, Grazyna
    Escors, David
    [J]. LIFE-BASEL, 2022, 12 (04):
  • [6] Immunotherapy and immunoengineering for breast cancer; a comprehensive insight into CAR-T cell therapy advancements, challenges and prospects
    Azam Bozorgi
    Maryam Bozorgi
    Mozafar Khazaei
    [J]. Cellular Oncology, 2022, 45 : 755 - 777
  • [7] Immunotherapy and immunoengineering for breast cancer; a comprehensive insight into CAR-T cell therapy advancements, challenges and prospects
    Bozorgi, Azam
    Bozorgi, Maryam
    Khazaei, Mozafar
    [J]. CELLULAR ONCOLOGY, 2022, 45 (05) : 755 - 777
  • [8] CAR-T cells in oncology: challenges and opportunities
    Bondanza, A.
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2017, 47 : 38 - 38
  • [9] CAR-T Cell Therapy: Challenges and Optimization
    Luo, Mei
    Zhang, Hongchang
    Zhu, Linnan
    Xu, Qumiao
    Gao, Qianqian
    [J]. CRITICAL REVIEWS IN IMMUNOLOGY, 2021, 41 (01) : 77 - 87
  • [10] The Promise and Challenges of CAR-T Gene Therapy
    Kuehn, Bridget M.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (22): : 2167 - 2169
12345